{
  "section": "10k_item1a",
  "yearPairs": [
    {
      "from": 2015,
      "to": 2016,
      "topRisers": [
        {
          "term": "public",
          "score": 5.3,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.76,
          "deltaPer10k": 2.76,
          "distinctive": false
        },
        {
          "term": "Data breach",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false,
          "includes": [
            "security breaches"
          ]
        },
        {
          "term": "acquires outstanding",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "act creates",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "alleged violation",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "asserting patents",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "available hepatitis",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "belonging",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "belonging abbvie",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "billion expired",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "biopharmaceutical industry",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "boehringer",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "breaches employees",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "breakdown data",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        },
        {
          "term": "business partners",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.38,
          "deltaPer10k": 1.38,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "percent",
          "score": -6.23,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 6.97,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.97,
          "distinctive": false
        },
        {
          "term": "amgen",
          "score": -5.31,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.79,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.79,
          "distinctive": false
        },
        {
          "term": "abt",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "agency",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "biogen",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "conversion abbott",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "dyslipidemia",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "inhibitors",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "march",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "medicines",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "obtain desired",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "passed",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "protease",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "reduced party",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        },
        {
          "term": "relapsing",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.39,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.39,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on public, Data breach, acquires outstanding; de-emphasizes percent, amgen, abt.",
      "topRisersAlt": [
        {
          "term": "debt abbvie",
          "score": 5.29
        },
        {
          "term": "data privacy",
          "score": 0.67
        },
        {
          "term": "impact abbvie business",
          "score": 0.38
        },
        {
          "term": "results operations abbvie",
          "score": 0.38
        },
        {
          "term": "pharmaceutical products",
          "score": 0.2
        },
        {
          "term": "results operations",
          "score": 0.2
        },
        {
          "term": "abbvie common stock",
          "score": 0.16
        },
        {
          "term": "united states",
          "score": 0.07
        },
        {
          "term": "intellectual property",
          "score": 0.02
        },
        {
          "term": "market share",
          "score": -0.03
        },
        {
          "term": "patent infringement",
          "score": -0.03
        },
        {
          "term": "political instability",
          "score": -0.03
        },
        {
          "term": "supply chain",
          "score": -0.03
        },
        {
          "term": "abbvie future revenues",
          "score": -0.03
        },
        {
          "term": "abbvie operations",
          "score": -0.03
        }
      ],
      "topFallersAlt": [
        {
          "term": "common stock",
          "score": -5.34
        },
        {
          "term": "business results operations",
          "score": -0.32
        },
        {
          "term": "risks related abbvie",
          "score": -0.32
        },
        {
          "term": "abbvie ability",
          "score": -0.21
        },
        {
          "term": "abbvie products",
          "score": -0.03
        },
        {
          "term": "adversely affect abbvie",
          "score": -0.03
        },
        {
          "term": "abbvie business",
          "score": -0.03
        },
        {
          "term": "health care",
          "score": -0.03
        },
        {
          "term": "product liability",
          "score": -0.03
        },
        {
          "term": "abbvie business results",
          "score": -0.03
        },
        {
          "term": "abbvie intellectual property",
          "score": -0.03
        },
        {
          "term": "future revenues",
          "score": -0.03
        },
        {
          "term": "intellectual property rights",
          "score": -0.03
        },
        {
          "term": "laws regulations",
          "score": -0.03
        },
        {
          "term": "new products",
          "score": -0.03
        }
      ],
      "summaryAlt": "Adds emphasis on debt abbvie, data privacy, impact abbvie business; de-emphasizes common stock, business results operations, risks related abbvie."
    },
    {
      "from": 2016,
      "to": 2017,
      "topRisers": [
        {
          "term": "ensuring",
          "score": 5.31,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.78,
          "deltaPer10k": 2.78,
          "distinctive": false
        },
        {
          "term": "acceptance generating",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "achieving",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "achieving market",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "commercialization biosimilars",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "conversion abbott",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "creating",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "creating meeting",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "demand achieving",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "demand ensuring",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "distributors mckesson",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "does effectively",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "ensuring active",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "ensuring entire",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        },
        {
          "term": "generating",
          "score": 4.62,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.39,
          "deltaPer10k": 1.39,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "ability effectively",
          "score": -5.3,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.76,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.76,
          "distinctive": false
        },
        {
          "term": "pharmacyclics depend",
          "score": -5.3,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.76,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.76,
          "distinctive": false
        },
        {
          "term": "ability realize",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "arbitration biologics",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "authorization",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "boehringer",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "continuing changes",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "create",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "decline risks",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "ema",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "final",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "ibrutinib",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "imminent",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "ingelheim",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        },
        {
          "term": "injunction preventing",
          "score": -4.61,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.38,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.38,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on ensuring, acceptance generating, achieving; de-emphasizes ability effectively, pharmacyclics depend, ability realize.",
      "topRisersAlt": [
        {
          "term": "financial condition results",
          "score": 5.77
        },
        {
          "term": "abbvie revenues financial",
          "score": 5.36
        },
        {
          "term": "regulatory requirements",
          "score": 5.36
        },
        {
          "term": "abbvie subject",
          "score": 0.46
        },
        {
          "term": "affect abbvie results",
          "score": 0.46
        },
        {
          "term": "business results operations",
          "score": 0.34
        },
        {
          "term": "operations abbvie",
          "score": 0.34
        },
        {
          "term": "patent protection",
          "score": 0.34
        },
        {
          "term": "abbvie business",
          "score": 0.19
        },
        {
          "term": "intellectual property",
          "score": 0.05
        },
        {
          "term": "abbvie products",
          "score": 0.05
        },
        {
          "term": "adversely affect abbvie",
          "score": 0.05
        },
        {
          "term": "abbvie common stock",
          "score": 0.05
        },
        {
          "term": "health care",
          "score": 0.05
        },
        {
          "term": "product liability",
          "score": 0.05
        }
      ],
      "topFallersAlt": [
        {
          "term": "results operations abbvie",
          "score": -5.68
        },
        {
          "term": "addition abbvie",
          "score": -5.27
        },
        {
          "term": "approval abbvie",
          "score": -5.27
        },
        {
          "term": "business abbvie",
          "score": -5.27
        },
        {
          "term": "humira revenues",
          "score": -5.27
        },
        {
          "term": "regulatory approval",
          "score": -5.27
        },
        {
          "term": "pharmaceutical products",
          "score": -0.47
        },
        {
          "term": "results operations",
          "score": -0.47
        },
        {
          "term": "impact abbvie business",
          "score": -0.36
        },
        {
          "term": "risks related abbvie",
          "score": -0.36
        },
        {
          "term": "abbvie ability",
          "score": -0.18
        },
        {
          "term": "united states",
          "score": -0.16
        },
        {
          "term": "market share",
          "score": 0.05
        },
        {
          "term": "patent infringement",
          "score": 0.05
        },
        {
          "term": "political instability",
          "score": 0.05
        }
      ],
      "summaryAlt": "Adds emphasis on financial condition results, abbvie revenues financial, regulatory requirements; de-emphasizes results operations abbvie, addition abbvie, approval abbvie."
    },
    {
      "from": 2017,
      "to": 2018,
      "topRisers": [
        {
          "term": "critical",
          "score": 5.33,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.84,
          "deltaPer10k": 2.84,
          "distinctive": false
        },
        {
          "term": "principal products",
          "score": 5.33,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.84,
          "deltaPer10k": 2.84,
          "distinctive": false
        },
        {
          "term": "applications complex",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "arbitration biologics",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "biosimilar products",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "biosimilars material",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "biosimilars proposals",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "business harm",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "commercialize principal",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "commercialize products",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "competitors obtain",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "complex information",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "continuing changes",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "critical business",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        },
        {
          "term": "critical sensitive",
          "score": 4.64,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.42,
          "deltaPer10k": 1.42,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "imbruvica",
          "score": -6.66,
          "z": -0.67,
          "countPrev": 8,
          "countCurr": 0,
          "per10kPrev": 11.11,
          "per10kCurr": 0.0,
          "deltaPer10k": -11.11,
          "distinctive": false
        },
        {
          "term": "cia",
          "score": -6.19,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 6.94,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.94,
          "distinctive": false
        },
        {
          "term": "monetary",
          "score": -5.69,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 4.17,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.17,
          "distinctive": false
        },
        {
          "term": "probation",
          "score": -5.69,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 4.17,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.17,
          "distinctive": false
        },
        {
          "term": "activities depakote",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "approximately million",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "commercialize imbruvica",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "depakote",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "department",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "fails",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "fails comply",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "federal health",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "marketing activities",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "million",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        },
        {
          "term": "monetary penalties",
          "score": -5.28,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.78,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.78,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on critical, principal products, applications complex; de-emphasizes imbruvica, cia, monetary.",
      "topRisersAlt": [
        {
          "term": "addition abbvie",
          "score": 5.35
        },
        {
          "term": "business abbvie",
          "score": 5.35
        },
        {
          "term": "form abbvie",
          "score": 5.35
        },
        {
          "term": "abbvie product",
          "score": 0.44
        },
        {
          "term": "adversely affect business",
          "score": 0.44
        },
        {
          "term": "debt abbvie",
          "score": 0.44
        },
        {
          "term": "interest rates",
          "score": 0.44
        },
        {
          "term": "risks related abbvie",
          "score": 0.44
        },
        {
          "term": "results operations",
          "score": 0.33
        },
        {
          "term": "abbvie products",
          "score": 0.14
        },
        {
          "term": "intellectual property",
          "score": 0.04
        },
        {
          "term": "adversely affect abbvie",
          "score": 0.03
        },
        {
          "term": "abbvie common stock",
          "score": 0.03
        },
        {
          "term": "product liability",
          "score": 0.03
        },
        {
          "term": "abbvie ability",
          "score": 0.03
        }
      ],
      "topFallersAlt": [
        {
          "term": "sales marketing",
          "score": -5.69
        },
        {
          "term": "abbvie revenues financial",
          "score": -5.28
        },
        {
          "term": "example abbvie",
          "score": -5.28
        },
        {
          "term": "impact abbvie results",
          "score": -5.28
        },
        {
          "term": "product sales",
          "score": -5.28
        },
        {
          "term": "sales product",
          "score": -5.28
        },
        {
          "term": "health care",
          "score": -0.38
        },
        {
          "term": "abbvie subject",
          "score": -0.38
        },
        {
          "term": "united states",
          "score": -0.23
        },
        {
          "term": "abbvie business",
          "score": -0.1
        },
        {
          "term": "market share",
          "score": 0.03
        },
        {
          "term": "patent infringement",
          "score": 0.03
        },
        {
          "term": "political instability",
          "score": 0.03
        },
        {
          "term": "supply chain",
          "score": 0.03
        },
        {
          "term": "abbvie future revenues",
          "score": 0.03
        }
      ],
      "summaryAlt": "Adds emphasis on addition abbvie, business abbvie, form abbvie; de-emphasizes sales marketing, abbvie revenues financial, example abbvie."
    },
    {
      "from": 2018,
      "to": 2019,
      "topRisers": [
        {
          "term": "allergan",
          "score": 6.49,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 9.32,
          "deltaPer10k": 9.32,
          "distinctive": false
        },
        {
          "term": "combined",
          "score": 6.15,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.66,
          "deltaPer10k": 6.66,
          "distinctive": false
        },
        {
          "term": "personnel",
          "score": 6.15,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.66,
          "deltaPer10k": 6.66,
          "distinctive": false
        },
        {
          "term": "acquisition allergan",
          "score": 5.93,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 5.33,
          "deltaPer10k": 5.33,
          "distinctive": false
        },
        {
          "term": "consummation",
          "score": 5.93,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 5.33,
          "deltaPer10k": 5.33,
          "distinctive": false
        },
        {
          "term": "consummation acquisition",
          "score": 5.93,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 5.33,
          "deltaPer10k": 5.33,
          "distinctive": false
        },
        {
          "term": "completion",
          "score": 5.64,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 4.0,
          "deltaPer10k": 4.0,
          "distinctive": false
        },
        {
          "term": "pending",
          "score": 5.64,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 4.0,
          "deltaPer10k": 4.0,
          "distinctive": false
        },
        {
          "term": "qualified",
          "score": 5.64,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 4.0,
          "deltaPer10k": 4.0,
          "distinctive": false
        },
        {
          "term": "claims legal",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        },
        {
          "term": "financial statements",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        },
        {
          "term": "flexibility",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        },
        {
          "term": "highly qualified",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        },
        {
          "term": "investigations",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        },
        {
          "term": "proceedings investigations",
          "score": 5.24,
          "z": 0.52,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.66,
          "deltaPer10k": 2.66,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "acquisitions purposes",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "acquisitions technology",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "bidder",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "bidder encourage",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "bids making",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "bids unacceptably",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "circumvented extent",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "encourage prospective",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "expensive bidder",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "including sovereign",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "laws political",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "make approximately",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "making practices",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "practices bids",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        },
        {
          "term": "process including",
          "score": -4.68,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.42,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.42,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on allergan, combined, personnel; de-emphasizes acquisitions purposes, acquisitions technology, bidder.",
      "topRisersAlt": [
        {
          "term": "acquisition abbvie",
          "score": 5.65
        },
        {
          "term": "factors item",
          "score": 5.24
        },
        {
          "term": "humira revenues",
          "score": 5.24
        },
        {
          "term": "item business",
          "score": 5.24
        },
        {
          "term": "operations cash",
          "score": 5.24
        },
        {
          "term": "products abbvie",
          "score": 5.24
        },
        {
          "term": "abbvie subject",
          "score": 0.63
        },
        {
          "term": "future revenues",
          "score": 0.34
        },
        {
          "term": "data privacy",
          "score": 0.33
        },
        {
          "term": "impact abbvie business",
          "score": 0.33
        },
        {
          "term": "pharmaceutical products",
          "score": 0.22
        },
        {
          "term": "adversely affect abbvie",
          "score": 0.16
        },
        {
          "term": "abbvie business",
          "score": 0.06
        },
        {
          "term": "abbvie products",
          "score": 0.01
        },
        {
          "term": "intellectual property",
          "score": 0.01
        }
      ],
      "topFallersAlt": [
        {
          "term": "health care",
          "score": -6.09
        },
        {
          "term": "abbvie future revenues",
          "score": -5.39
        },
        {
          "term": "addition abbvie",
          "score": -5.39
        },
        {
          "term": "form abbvie",
          "score": -5.39
        },
        {
          "term": "results operations",
          "score": -0.78
        },
        {
          "term": "united states",
          "score": -0.08
        },
        {
          "term": "abbvie common stock",
          "score": -0.08
        },
        {
          "term": "product liability",
          "score": -0.08
        },
        {
          "term": "abbvie ability",
          "score": -0.08
        },
        {
          "term": "abbvie business results",
          "score": -0.08
        },
        {
          "term": "abbvie intellectual property",
          "score": -0.08
        },
        {
          "term": "business results operations",
          "score": -0.08
        },
        {
          "term": "intellectual property rights",
          "score": -0.08
        },
        {
          "term": "operations abbvie",
          "score": -0.08
        },
        {
          "term": "patent protection",
          "score": -0.08
        }
      ],
      "summaryAlt": "Adds emphasis on acquisition abbvie, factors item, humira revenues; de-emphasizes health care, abbvie future revenues, addition abbvie."
    },
    {
      "from": 2019,
      "to": 2020,
      "topRisers": [
        {
          "term": "COVID-19",
          "score": 6.72,
          "z": 0.67,
          "countPrev": 0,
          "countCurr": 9,
          "per10kPrev": 0.0,
          "per10kCurr": 11.01,
          "deltaPer10k": 11.01,
          "distinctive": false,
          "includes": [
            "covid"
          ]
        },
        {
          "term": "intangible",
          "score": 6.6,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 8,
          "per10kPrev": 0.0,
          "per10kCurr": 9.79,
          "deltaPer10k": 9.79,
          "distinctive": false
        },
        {
          "term": "Pandemic",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.12,
          "deltaPer10k": 6.12,
          "distinctive": false,
          "includes": [
            "pandemics",
            "pandemic"
          ]
        },
        {
          "term": "developed",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.12,
          "deltaPer10k": 6.12,
          "distinctive": false
        },
        {
          "term": "intangible assets",
          "score": 6.13,
          "z": 0.61,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.12,
          "deltaPer10k": 6.12,
          "distinctive": false
        },
        {
          "term": "asset",
          "score": 5.91,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.89,
          "deltaPer10k": 4.89,
          "distinctive": false
        },
        {
          "term": "developed product",
          "score": 5.91,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.89,
          "deltaPer10k": 4.89,
          "distinctive": false
        },
        {
          "term": "party service",
          "score": 5.91,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.89,
          "deltaPer10k": 4.89,
          "distinctive": false
        },
        {
          "term": "carrying",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "caused",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "impact covid",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "ipr",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "joint",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "joint ventures",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        },
        {
          "term": "service providers",
          "score": 5.62,
          "z": 0.56,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.67,
          "deltaPer10k": 3.67,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "combined",
          "score": -6.3,
          "z": -0.63,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 6.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -6.66,
          "distinctive": false
        },
        {
          "term": "consummation",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 5.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.33,
          "distinctive": false
        },
        {
          "term": "consummation acquisition",
          "score": -6.08,
          "z": -0.61,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 5.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.33,
          "distinctive": false
        },
        {
          "term": "completion",
          "score": -5.79,
          "z": -0.58,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 4.0,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.0,
          "distinctive": false
        },
        {
          "term": "transaction",
          "score": -5.39,
          "z": -0.54,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.66,
          "distinctive": false
        },
        {
          "term": "virology",
          "score": -5.39,
          "z": -0.54,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.66,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.66,
          "distinctive": false
        },
        {
          "term": "act individual",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "action inflation",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "actual changes",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "alliances pharmaceutical",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "alliances restructurings",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "announcement",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "anticipated benefits",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "arbitration biologics",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        },
        {
          "term": "arrangements strategic",
          "score": -4.7,
          "z": -0.47,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.33,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.33,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on COVID-19, intangible, Pandemic; de-emphasizes combined, consummation, consummation acquisition.",
      "topRisersAlt": [
        {
          "term": "material adverse",
          "score": 6.93
        },
        {
          "term": "research development",
          "score": 6.3
        },
        {
          "term": "health care",
          "score": 5.89
        },
        {
          "term": "product rights",
          "score": 5.89
        },
        {
          "term": "stock abbvie",
          "score": 5.89
        },
        {
          "term": "abbvie operations financial",
          "score": 5.6
        },
        {
          "term": "abbvie future revenues",
          "score": 5.19
        },
        {
          "term": "abbvie results operations",
          "score": 5.19
        },
        {
          "term": "addition abbvie",
          "score": 5.19
        },
        {
          "term": "form abbvie",
          "score": 5.19
        },
        {
          "term": "future adverse impact",
          "score": 5.19
        },
        {
          "term": "impact abbvie results",
          "score": 5.19
        },
        {
          "term": "results operations financial",
          "score": 5.19
        },
        {
          "term": "significant debt",
          "score": 5.19
        },
        {
          "term": "abbvie operations",
          "score": 0.57
        }
      ],
      "topFallersAlt": [
        {
          "term": "abbvie common stock",
          "score": -6.56
        },
        {
          "term": "acquisition abbvie",
          "score": -5.85
        },
        {
          "term": "abbvie patents",
          "score": -5.44
        },
        {
          "term": "business abbvie",
          "score": -5.44
        },
        {
          "term": "common stock abbvie",
          "score": -5.44
        },
        {
          "term": "factors item",
          "score": -5.44
        },
        {
          "term": "humira revenues",
          "score": -5.44
        },
        {
          "term": "item business",
          "score": -5.44
        },
        {
          "term": "operations cash",
          "score": -5.44
        },
        {
          "term": "abbvie subject",
          "score": -0.83
        },
        {
          "term": "adversely affect business",
          "score": -0.54
        },
        {
          "term": "debt abbvie",
          "score": -0.54
        },
        {
          "term": "impact abbvie business",
          "score": -0.54
        },
        {
          "term": "abbvie business",
          "score": -0.43
        },
        {
          "term": "future revenues",
          "score": -0.32
        }
      ],
      "summaryAlt": "Adds emphasis on material adverse, research development, health care; de-emphasizes abbvie common stock, acquisition abbvie, abbvie patents."
    },
    {
      "from": 2020,
      "to": 2021,
      "topRisers": [
        {
          "term": "Climate change",
          "score": 5.3,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.43,
          "deltaPer10k": 2.43,
          "distinctive": false,
          "includes": [
            "climate change"
          ]
        },
        {
          "term": "attract develop",
          "score": 5.3,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.43,
          "deltaPer10k": 2.43,
          "distinctive": false
        },
        {
          "term": "develop retain",
          "score": 5.3,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.43,
          "deltaPer10k": 2.43,
          "distinctive": false
        },
        {
          "term": "mitigate",
          "score": 5.3,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.43,
          "deltaPer10k": 2.43,
          "distinctive": false
        },
        {
          "term": "actual changes",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "arbitration biologics",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "breaches cause",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "business interruptions",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "change earthquakes",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "climate",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "completely",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "countries potential",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "disasters changes",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "disasters climate",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        },
        {
          "term": "diverse",
          "score": 4.61,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.22,
          "deltaPer10k": 1.22,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "action taken",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "america potential",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "care inability",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "europe latin",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "including europe",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "latin",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "latin america",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "laws political",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "newly",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "outbreak",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "plans addition",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "portfolio",
          "score": -4.62,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "attract retain",
          "score": -0.7,
          "z": -0.81,
          "countPrev": 4,
          "countCurr": 2,
          "per10kPrev": 4.89,
          "per10kCurr": 2.43,
          "deltaPer10k": -2.46,
          "distinctive": false
        },
        {
          "term": "america",
          "score": -0.69,
          "z": -0.57,
          "countPrev": 2,
          "countCurr": 1,
          "per10kPrev": 2.45,
          "per10kCurr": 1.22,
          "deltaPer10k": -1.23,
          "distinctive": false
        },
        {
          "term": "countries including",
          "score": -0.69,
          "z": -0.57,
          "countPrev": 2,
          "countCurr": 1,
          "per10kPrev": 2.45,
          "per10kCurr": 1.22,
          "deltaPer10k": -1.23,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on Climate change, attract develop, develop retain; de-emphasizes action taken, america potential, care inability.",
      "topRisersAlt": [
        {
          "term": "products form",
          "score": 5.31
        },
        {
          "term": "climate change",
          "score": 4.62
        },
        {
          "term": "abbvie subject",
          "score": 0.4
        },
        {
          "term": "adversely affect business",
          "score": 0.4
        },
        {
          "term": "laws regulations",
          "score": 0.29
        },
        {
          "term": "market share",
          "score": -0.0
        },
        {
          "term": "patent infringement",
          "score": -0.0
        },
        {
          "term": "political instability",
          "score": -0.0
        },
        {
          "term": "abbvie future revenues",
          "score": -0.0
        },
        {
          "term": "abbvie results operations",
          "score": -0.0
        },
        {
          "term": "abbvie revenues",
          "score": -0.0
        },
        {
          "term": "debt abbvie",
          "score": -0.0
        },
        {
          "term": "development manufacturing",
          "score": -0.0
        },
        {
          "term": "factors cause",
          "score": -0.0
        },
        {
          "term": "future adverse impact",
          "score": -0.0
        }
      ],
      "topFallersAlt": [
        {
          "term": "addition abbvie",
          "score": -5.32
        },
        {
          "term": "form abbvie",
          "score": -5.32
        },
        {
          "term": "abbvie operations financial",
          "score": -0.41
        },
        {
          "term": "intellectual property",
          "score": -0.01
        },
        {
          "term": "abbvie products",
          "score": -0.0
        },
        {
          "term": "material adverse",
          "score": -0.0
        },
        {
          "term": "adversely affect abbvie",
          "score": -0.0
        },
        {
          "term": "united states",
          "score": -0.0
        },
        {
          "term": "abbvie business",
          "score": -0.0
        },
        {
          "term": "research development",
          "score": -0.0
        },
        {
          "term": "business results operations",
          "score": -0.0
        },
        {
          "term": "future revenues",
          "score": -0.0
        },
        {
          "term": "patent protection",
          "score": -0.0
        },
        {
          "term": "product liability",
          "score": -0.0
        },
        {
          "term": "abbvie ability",
          "score": -0.0
        }
      ],
      "summaryAlt": "Adds emphasis on products form, climate change, abbvie subject; de-emphasizes addition abbvie, form abbvie, abbvie operations financial."
    },
    {
      "from": 2021,
      "to": 2022,
      "topRisers": [
        {
          "term": "beginning",
          "score": 6.51,
          "z": 0.65,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 8.19,
          "deltaPer10k": 8.19,
          "distinctive": false
        },
        {
          "term": "counterfeit",
          "score": 6.36,
          "z": 0.64,
          "countPrev": 0,
          "countCurr": 6,
          "per10kPrev": 0.0,
          "per10kCurr": 7.02,
          "deltaPer10k": 7.02,
          "distinctive": false
        },
        {
          "term": "diverted",
          "score": 6.18,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 5.85,
          "deltaPer10k": 5.85,
          "distinctive": false
        },
        {
          "term": "russia",
          "score": 6.18,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 5.85,
          "deltaPer10k": 5.85,
          "distinctive": false
        },
        {
          "term": "healthcare",
          "score": 5.96,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.68,
          "deltaPer10k": 4.68,
          "distinctive": false
        },
        {
          "term": "inflation reduction",
          "score": 5.96,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.68,
          "deltaPer10k": 4.68,
          "distinctive": false
        },
        {
          "term": "reduction act",
          "score": 5.96,
          "z": 0.59,
          "countPrev": 0,
          "countCurr": 4,
          "per10kPrev": 0.0,
          "per10kCurr": 4.68,
          "deltaPer10k": 4.68,
          "distinctive": false
        },
        {
          "term": "cap",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "components",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "counterfeit diverted",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "coverage",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "determined",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "healthcare industry",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "materials components",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        },
        {
          "term": "versions",
          "score": 5.67,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.51,
          "deltaPer10k": 3.51,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "future revenues",
          "score": -6.59,
          "z": -0.66,
          "countPrev": 7,
          "countCurr": 0,
          "per10kPrev": 8.52,
          "per10kCurr": 0.0,
          "deltaPer10k": -8.52,
          "distinctive": false
        },
        {
          "term": "acquisition allergan",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "adversely affects",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "affects",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "affects humira",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "connection acquisition",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "event adversely",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "failure single",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "humira revenues",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "licenses adversely",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "reduction future",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "significant event",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "uses number",
          "score": -5.34,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.43,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.43,
          "distinctive": false
        },
        {
          "term": "abbvie largest",
          "score": -4.65,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        },
        {
          "term": "accordingly results",
          "score": -4.65,
          "z": -0.46,
          "countPrev": 1,
          "countCurr": 0,
          "per10kPrev": 1.22,
          "per10kCurr": 0.0,
          "deltaPer10k": -1.22,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on beginning, counterfeit, diverted; de-emphasizes future revenues, acquisition allergan, adversely affects.",
      "topRisersAlt": [
        {
          "term": "addition abbvie",
          "score": 5.69
        },
        {
          "term": "abbvie products material",
          "score": 5.28
        },
        {
          "term": "abbvie revenues financial",
          "score": 5.28
        },
        {
          "term": "adverse impact",
          "score": 5.28
        },
        {
          "term": "consequences include",
          "score": 5.28
        },
        {
          "term": "failure significant",
          "score": 5.28
        },
        {
          "term": "export controls",
          "score": 4.59
        },
        {
          "term": "abbvie operations",
          "score": 0.38
        },
        {
          "term": "abbvie revenues",
          "score": 0.38
        },
        {
          "term": "impact abbvie business",
          "score": 0.38
        },
        {
          "term": "products united states",
          "score": 0.38
        },
        {
          "term": "results operations financial",
          "score": 0.38
        },
        {
          "term": "business results operations",
          "score": 0.31
        },
        {
          "term": "research development",
          "score": 0.26
        },
        {
          "term": "abbvie product",
          "score": 0.26
        }
      ],
      "topFallersAlt": [
        {
          "term": "future revenues",
          "score": -6.27
        },
        {
          "term": "patent protection",
          "score": -6.27
        },
        {
          "term": "abbvie future revenues",
          "score": -5.34
        },
        {
          "term": "abbvie results operations",
          "score": -5.34
        },
        {
          "term": "debt abbvie",
          "score": -5.34
        },
        {
          "term": "impact abbvie results",
          "score": -5.34
        },
        {
          "term": "intellectual property protection",
          "score": -5.34
        },
        {
          "term": "products form",
          "score": -5.34
        },
        {
          "term": "products pharmaceutical",
          "score": -5.34
        },
        {
          "term": "significant debt",
          "score": -5.34
        },
        {
          "term": "abbvie ability",
          "score": -0.32
        },
        {
          "term": "material adverse",
          "score": -0.24
        },
        {
          "term": "united states",
          "score": -0.14
        },
        {
          "term": "abbvie business",
          "score": -0.03
        },
        {
          "term": "abbvie business results",
          "score": -0.03
        }
      ],
      "summaryAlt": "Adds emphasis on addition abbvie, abbvie products material, abbvie revenues financial; de-emphasizes future revenues, patent protection, abbvie future revenues."
    },
    {
      "from": 2022,
      "to": 2023,
      "topRisers": [
        {
          "term": "ira",
          "score": 6.57,
          "z": 0.66,
          "countPrev": 0,
          "countCurr": 7,
          "per10kPrev": 0.0,
          "per10kCurr": 8.3,
          "deltaPer10k": 8.3,
          "distinctive": false
        },
        {
          "term": "selected",
          "score": 5.72,
          "z": 0.57,
          "countPrev": 0,
          "countCurr": 3,
          "per10kPrev": 0.0,
          "per10kCurr": 3.56,
          "deltaPer10k": 3.56,
          "distinctive": false
        },
        {
          "term": "august",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "beginning january",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "cms",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "costs threshold",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "department",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "department health",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "drug costs",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "health human",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "human services",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "impact ira",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "incurred pocket",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "january",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        },
        {
          "term": "pocket drug",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.37,
          "deltaPer10k": 2.37,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "russia",
          "score": -6.2,
          "z": -0.62,
          "countPrev": 5,
          "countCurr": 0,
          "per10kPrev": 5.85,
          "per10kCurr": 0.0,
          "deltaPer10k": -5.85,
          "distinctive": false
        },
        {
          "term": "impact covid",
          "score": -5.98,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 4.68,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.68,
          "distinctive": false
        },
        {
          "term": "inflation reduction",
          "score": -5.98,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 4.68,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.68,
          "distinctive": false
        },
        {
          "term": "reduction act",
          "score": -5.98,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 4.68,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.68,
          "distinctive": false
        },
        {
          "term": "cap",
          "score": -5.69,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 3.51,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.51,
          "distinctive": false
        },
        {
          "term": "agency",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "belarus",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "conflict",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "forthcoming",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "implemented",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "member",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "opioid",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "outbreak",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "reasonably",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        },
        {
          "term": "settlement",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.34,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.34,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on ira, selected, august; de-emphasizes russia, impact covid, inflation reduction.",
      "topRisersAlt": [
        {
          "term": "additional costs",
          "score": 5.35
        },
        {
          "term": "certain products",
          "score": 5.35
        },
        {
          "term": "form abbvie",
          "score": 5.35
        },
        {
          "term": "product requirements",
          "score": 5.35
        },
        {
          "term": "time abbvie",
          "score": 5.35
        },
        {
          "term": "impact abbvie business",
          "score": 0.33
        },
        {
          "term": "abbvie business",
          "score": 0.2
        },
        {
          "term": "abbvie products",
          "score": 0.19
        },
        {
          "term": "intellectual property",
          "score": 0.16
        },
        {
          "term": "adversely affect abbvie",
          "score": 0.04
        },
        {
          "term": "united states",
          "score": 0.04
        },
        {
          "term": "research development",
          "score": 0.04
        },
        {
          "term": "business results operations",
          "score": 0.04
        },
        {
          "term": "product liability",
          "score": 0.04
        },
        {
          "term": "intellectual property rights",
          "score": 0.04
        }
      ],
      "topFallersAlt": [
        {
          "term": "material adverse",
          "score": -6.81
        },
        {
          "term": "addition abbvie",
          "score": -5.68
        },
        {
          "term": "abbvie products material",
          "score": -5.28
        },
        {
          "term": "adverse impact",
          "score": -5.28
        },
        {
          "term": "consequences include",
          "score": -5.28
        },
        {
          "term": "export controls",
          "score": -4.58
        },
        {
          "term": "supply chain",
          "score": -0.66
        },
        {
          "term": "abbvie operations",
          "score": -0.38
        },
        {
          "term": "abbvie business results",
          "score": -0.26
        },
        {
          "term": "operations abbvie",
          "score": -0.26
        },
        {
          "term": "pharmaceutical products",
          "score": -0.19
        },
        {
          "term": "climate change",
          "score": 0.04
        },
        {
          "term": "market share",
          "score": 0.04
        },
        {
          "term": "patent infringement",
          "score": 0.04
        },
        {
          "term": "political instability",
          "score": 0.04
        }
      ],
      "summaryAlt": "Adds emphasis on additional costs, certain products, form abbvie; de-emphasizes material adverse, addition abbvie, abbvie products material."
    },
    {
      "from": 2023,
      "to": 2024,
      "topRisers": [
        {
          "term": "Artificial intelligence",
          "score": 6.23,
          "z": 0.62,
          "countPrev": 0,
          "countCurr": 5,
          "per10kPrev": 0.0,
          "per10kCurr": 6.01,
          "deltaPer10k": 6.01,
          "distinctive": false,
          "includes": [
            "artificial intelligence",
            "ai"
          ]
        },
        {
          "term": "advantages",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.4,
          "deltaPer10k": 2.4,
          "distinctive": false
        },
        {
          "term": "artificial",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.4,
          "deltaPer10k": 2.4,
          "distinctive": false
        },
        {
          "term": "hhs",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.4,
          "deltaPer10k": 2.4,
          "distinctive": false
        },
        {
          "term": "intelligence",
          "score": 5.32,
          "z": 0.53,
          "countPrev": 0,
          "countCurr": 2,
          "per10kPrev": 0.0,
          "per10kCurr": 2.4,
          "deltaPer10k": 2.4,
          "distinctive": false
        },
        {
          "term": "adequately",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "adopt",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "advancements",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "analyses",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "bring",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "care costs",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "cencora",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "conflicts",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "creon",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        },
        {
          "term": "crises",
          "score": 4.63,
          "z": 0.46,
          "countPrev": 0,
          "countCurr": 1,
          "per10kPrev": 0.0,
          "per10kCurr": 1.2,
          "deltaPer10k": 1.2,
          "distinctive": false
        }
      ],
      "topFallers": [
        {
          "term": "COVID-19",
          "score": -5.98,
          "z": -0.6,
          "countPrev": 4,
          "countCurr": 0,
          "per10kPrev": 4.74,
          "per10kCurr": 0.0,
          "deltaPer10k": -4.74,
          "distinctive": false,
          "includes": [
            "covid"
          ]
        },
        {
          "term": "caused",
          "score": -5.69,
          "z": -0.57,
          "countPrev": 3,
          "countCurr": 0,
          "per10kPrev": 3.56,
          "per10kCurr": 0.0,
          "deltaPer10k": -3.56,
          "distinctive": false
        },
        {
          "term": "Coronavirus",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false,
          "includes": [
            "coronavirus"
          ]
        },
        {
          "term": "allergan",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "coronavirus covid",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "covid pandemic",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "customers business",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "epidemics pandemics",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "example humira",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "health outbreaks",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "orders",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "outbreaks",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "outbreaks epidemics",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "pandemic caused",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        },
        {
          "term": "public health",
          "score": -5.29,
          "z": -0.53,
          "countPrev": 2,
          "countCurr": 0,
          "per10kPrev": 2.37,
          "per10kCurr": 0.0,
          "deltaPer10k": -2.37,
          "distinctive": false
        }
      ],
      "summary": "Adds emphasis on Artificial intelligence, advantages, artificial; de-emphasizes COVID-19, caused, Coronavirus.",
      "topRisersAlt": [
        {
          "term": "artificial intelligence",
          "score": 5.33
        },
        {
          "term": "consequences include",
          "score": 5.33
        },
        {
          "term": "result abbvie",
          "score": 5.33
        },
        {
          "term": "subject government",
          "score": 5.33
        },
        {
          "term": "labor shortages",
          "score": 4.64
        },
        {
          "term": "supply chain",
          "score": 0.71
        },
        {
          "term": "results operations",
          "score": 0.43
        },
        {
          "term": "abbvie revenues",
          "score": 0.31
        },
        {
          "term": "new products",
          "score": 0.25
        },
        {
          "term": "pharmaceutical products",
          "score": 0.25
        },
        {
          "term": "abbvie business",
          "score": 0.16
        },
        {
          "term": "abbvie products",
          "score": 0.02
        },
        {
          "term": "adversely affect abbvie",
          "score": 0.02
        },
        {
          "term": "business results operations",
          "score": 0.02
        },
        {
          "term": "product liability",
          "score": 0.02
        }
      ],
      "topFallersAlt": [
        {
          "term": "financial condition results",
          "score": -5.7
        },
        {
          "term": "abbvie operations financial",
          "score": -5.29
        },
        {
          "term": "additional costs",
          "score": -5.29
        },
        {
          "term": "future adverse impact",
          "score": -5.29
        },
        {
          "term": "product requirements",
          "score": -5.29
        },
        {
          "term": "abbvie subject",
          "score": -0.39
        },
        {
          "term": "affect abbvie results",
          "score": -0.39
        },
        {
          "term": "products united states",
          "score": -0.39
        },
        {
          "term": "regulatory requirements",
          "score": -0.39
        },
        {
          "term": "abbvie operations",
          "score": -0.27
        },
        {
          "term": "united states",
          "score": -0.24
        },
        {
          "term": "research development",
          "score": -0.12
        },
        {
          "term": "intellectual property",
          "score": -0.02
        },
        {
          "term": "climate change",
          "score": 0.02
        },
        {
          "term": "market share",
          "score": 0.02
        }
      ],
      "summaryAlt": "Adds emphasis on artificial intelligence, consequences include, result abbvie; de-emphasizes financial condition results, abbvie operations financial, additional costs."
    }
  ]
}